LR19024
/ LG Chem
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
May 03, 2024
A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of LG00034053 in Patients With Knee OA
(clinicaltrials.gov)
- P1/2 | N=74 | Completed | Sponsor: LG Chem | Active, not recruiting ➔ Completed | Trial completion date: Nov 2024 ➔ Mar 2024 | Trial primary completion date: Mar 2024 ➔ Dec 2023
Trial completion • Trial completion date • Trial primary completion date • Immunology • Osteoarthritis • Pain • Rheumatology
February 09, 2024
A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of LG00034053 in Patients With Knee OA
(clinicaltrials.gov)
- P1/2 | N=74 | Active, not recruiting | Sponsor: LG Chem | Recruiting ➔ Active, not recruiting
Enrollment closed • Immunology • Osteoarthritis • Pain • Rheumatology
March 09, 2023
A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of LG00034053 in Patients With Knee OA
(clinicaltrials.gov)
- P1/2 | N=135 | Recruiting | Sponsor: LG Chem | Trial completion date: Dec 2023 ➔ Nov 2024 | Trial primary completion date: Dec 2022 ➔ Mar 2024
Trial completion date • Trial primary completion date • Immunology • Osteoarthritis • Pain • Rheumatology
1 to 3
Of
3
Go to page
1